跳轉至內容
Merck

TMEM163 Regulates ATP-Gated P2X Receptor and Behavior.

Cell reports (2020-06-04)
Elizabeth J Salm, Patrick J Dunn, Lili Shan, Miwako Yamasaki, Nathalie M Malewicz, Taisuke Miyazaki, Joongkyu Park, Akio Sumioka, R Richard L Hamer, Wei-Wu He, Megumi Morimoto-Tomita, Robert H LaMotte, Susumu Tomita
摘要

Fast purinergic signaling is mediated by ATP and ATP-gated ionotropic P2X receptors (P2XRs), and it is implicated in pain-related behaviors. The properties exhibited by P2XRs vary between those expressed in heterologous cells and in vivo. Several modulators of ligand-gated ion channels have recently been identified, suggesting that there are P2XR functional modulators in vivo. Here, we establish a genome-wide open reading frame (ORF) collection and perform functional screening to identify modulators of P2XR activity. We identify TMEM163, which specifically modulates the channel properties and pharmacology of P2XRs. We also find that TMEM163 is required for full function of the neuronal P2XR and a pain-related ATP-evoked behavior. These results establish TMEM163 as a critical modulator of P2XRs in vivo and a potential target for the discovery of drugs for treating pain.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
单克隆抗-FLAG® M2 小鼠抗, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)
Sigma-Aldrich
抗 α-微管蛋白单克隆抗体 小鼠抗, clone DM1A, ascites fluid
Sigma-Aldrich
二氯甲基二乙胺 盐酸盐, 98%
Sigma-Aldrich
Cyclothiazide
Sigma-Aldrich
N-Acetyl-DL-aspartic acid, ≥95%